{{Rsnum
|rsid=2679118
|Gene=CILP
|Chromosome=15
|position=65198563
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0.01056
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 89.0 | 10.3 | 0.7
| ASW | 86.0 | 14.0 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 93.6 | 6.4 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 96.8 | 3.2 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{Venter SNP
|rsid=2679118
|allele=C
|frequency=1
|uid=1103645637353
|type=homozygous_SNP
|hugo=CILP
|ensembl gene=ENSG00000138615
|ensembl transcript=ENST00000261883
|sift=TOLERATED
|disease=Antibodies against CILP are detected in patients with early-stage knee osteoarthritis (OA) and rheumatoid arthritis (RA). Autoantibodies against the C1 and C2 chains are detected in 10 out of 136 and 17 out of 136 patient with OA, respectively.
}}

{{GET Evidence
|gene=CILP
|aa_change=Lys575Glu
|aa_change_short=K575E
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2679118
|overall_frequency_n=10611
|overall_frequency_d=10758
|overall_frequency=0.986336
|n_genomes=56
|n_genomes_annotated=0
|n_haplomes=111
|n_articles=0
|n_articles_annotated=0
|nblosum100=0
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}